๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Multiple Sclerosis

Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System NCT05493514n/a1 site๐Ÿ“ Milan Fondazione Don Carlo Gnocchi ETS ยท Tests: Robotic Assisted Gait Training with G-EO system Genes and Environment in Multiple Sclerosis NCT01353547n/a5 sites๐Ÿ“ Bethesda๐Ÿ“ Boston๐Ÿ“ Boston Columbia University Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis NCT07220252Phase 2, Phase 36 sites๐Ÿ“ Salt Lake City๐Ÿ“ Gdansk๐Ÿ“ Poznan TG Therapeutics, Inc. ยท Tests: Ublituximab, Placebo, Placebo, Fingolimod Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia NCT07732907n/a1 site๐Ÿ“ Lawrenceville Bristol-Myers Squibb ยท Tests: Ozanimod BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis NCT07507084NA1 site๐Ÿ“ Kรผtahya Kutahya Health Sciences University ยท Tests: Internal Focus Dual-Task Training, External Focus Dual-Task Training A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site๐Ÿ“ Montpellier University Hospital, Montpellier ยท Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrelโ€ฆ Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS? NCT07225868NA3 sites๐Ÿ“ Buffalo๐Ÿ“ Leiden๐Ÿ“ Rheinfelden Universiteit Leiden ยท Tests: Conscientiousness Coaching Before Cognitive Rehabilitation, Sham Intervention Before Cognitive Rehabilitation Blood Flow Restriction And Veterans With MS NCT05433103NA1 site๐Ÿ“ Aurora VA Office of Research and Development ยท Tests: Low-Load Exercise with Blood Flow Restriction, Low-Load Exercise Control Group Solriamfetol for the Treatment of Multiple Sclerosis Fatigue NCT06170970Phase 21 site๐Ÿ“ Baltimore Johns Hopkins University ยท Tests: Solriamfetol, Placebo Impact of TTNS on Bladder Symptoms Among People With MS, A RCT NCT06341673NA1 site๐Ÿ“ Khobar Hawra Al-Dandan ยท Tests: Active Transcutaneous Electrical Nerve Stimulation (TENS), Sham Transcutaneous Electrical Nerve Stimulation (TENS) Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494n/a1 site๐Ÿ“ Marseille Assistance Publique Hopitaux De Marseille ยท Tests: Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging) Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis NCT04603196n/a1 site๐Ÿ“ Boston Beth Israel Deaconess Medical Center A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis NCT07827716Phase 21 site๐Ÿ“ Wuhan Chuan Qin ยท Tests: Terfenadine, Standard First-line Disease-Modifying Therapy From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis NCT04873492NA1 site๐Ÿ“ Nantes Nantes University Hospital ยท Tests: Biological sample collection Study of the Disease Process of Lymphangioleiomyomatosis NCT00001465n/a1 site๐Ÿ“ Bethesda National Heart, Lung, and Blood Institute (NHLBI) ยท Tests: Toshibia Aquilion One CT Gait Adaptation Study NCT07660601EARLY Phase 11 site๐Ÿ“ Newark Rutgers, The State University of New Jersey ยท Tests: Gait Adaptation Training, Basic Physical Training BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis NCT06221631n/a1 site๐Ÿ“ Bern Insel Gruppe AG, University Hospital Bern Biomarkers of Synaptic Damage in Multiple Sclerosis NCT03217396n/a1 site๐Ÿ“ Pozzilli Neuromed IRCCS ยท Tests: lumbar puncture Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences NCT04819737NA1 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: SC MRI, patient questionnaire Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis NCT06256575NA5 sites๐Ÿ“ Calgary๐Ÿ“ Halifax๐Ÿ“ London Primus Pharmaceuticals ยท Tests: Diosmin, Placebo Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI NCT06955832n/a3 sites๐Ÿ“ Banhฤ๐Ÿ“ Cairo๐Ÿ“ Cairo Benha University Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target NCT03850301NA1 site๐Ÿ“ London Imperial College London ยท Tests: XBD173, Etifoxine Smoldering Inflammation in MS NCT06591429n/a1 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: Radiotracer [11C]-CS1P1, Radiotracer [11C]-DPA-713, anti-CD20 MS treatment, Radiotracer [12F]-FDG The Effect of a Probiotic Administration as an add-on Treatment in Multiple Sclerosis NCT07168772NA1 site๐Ÿ“ Barcelona Hospital Universitari Vall d'Hebron Research Institute ยท Tests: Lactibane Iki, Placebo Retinal Imaging in Neurodegenerative Disease NCT03233646n/a1 site๐Ÿ“ Durham Duke University ยท Tests: Retinal and Choroidal Imaging Monitoring Intensity During Balance Training in Persons With Multiple Sclerosis NCT07805850NA1 site๐Ÿ“ Valens Klinik Valens ยท Tests: Balance training, Sporttherapy Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis NCT02912897Phase 11 site๐Ÿ“ Nantes Nantes University Hospital ยท Tests: Cellular therapy with EBV specific autologous CTL infusion Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis NCT06592703Phase 12 sites๐Ÿ“ Crรฉteil๐Ÿ“ Rennes Rennes University Hospital ยท Tests: Adipose tissue-derived Mesenchymal Stromal Cells Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC) NCT07403266Phase 31 site๐Ÿ“ Madrid Oils4Cure ยท Tests: YCJ-01 Full Spectrum cannbis Extract, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy